[8-K] Equitable Holdings, Inc. Reports Material Event

Rhea-AI Filing Summary

Equitable Holdings, Inc. terminated several bilateral letter of credit facilities under its February 16, 2018 reimbursement agreements with multiple banking counterparties. On Aug 21, 2025, the company ended facilities with Barclays Bank PLC, Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A., Landesbank Hessen-Thüringen Girozentrale (New York Branch), and Natixis, New York Branch. On Aug 26, 2025, the company terminated the facility with Citibank Europe PLC. The filing lists these terminations as material definitive agreement changes and includes an exhibits reference for the 8-K.

Positive

• Formal termination of bilateral letter of credit facilities with six named banks on Aug 21, 2025 and Aug 26, 2025
• Consolidation of agreements by ending the February 16, 2018 reimbursement agreements with specific counterparties

Negative

• No disclosure in the filing of replacement facilities or the effect on existing letters of credit or contingent funding
• Potential operational impact from removing multiple international banking counterparties without stated transition details

Insights

Corporate Treasurer

Liquidity arrangement closures; reduces active reimbursement agreements with six banks.

The company has formally ended bilateral letter of credit facilities executed under the February 16, 2018 reimbursement agreements with six named banking counterparties on Aug 21, 2025 and Aug 26, 2025. This removes those specific contractual reimbursement obligations tied to those standby letters of credit.

Dependence now shifts to remaining liquidity or credit arrangements not listed here; any near-term cash or collateral effects depend on whether replacement facilities were arranged, which is not disclosed. Monitor subsequent disclosures or exhibits for replacement agreements or changes in contingent funding sources within the next few weeks.

Risk & Compliance Analyst

Operational and counterparty footprint has changed; compliance records must be updated.

Terminating reimbursement agreements with multiple international banks alters the company’s counterparty list for letters of credit and associated operational workflows. The action is limited to the bilateral facilities named and cites the original agreement date of Feb 16, 2018.

This filing does not disclose replacement credit lines or any impact on existing letters of credit; review regulatory filings or exhibits for evidence of replacement arrangements or residual contingent exposures over the next month.

0001333986false00013339862025-08-212025-08-210001333986exch:XNYSus-gaap:CommonClassAMember2025-08-212025-08-210001333986exch:XNYSus-gaap:SeriesAPreferredStockMember2025-08-212025-08-210001333986exch:XNYSus-gaap:SeriesCPreferredStockMember2025-08-212025-08-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 21, 2025

Equitable Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware			001-38469			90-0226248
(State or other jurisdiction of			(Commission File Number)			(I.R.S. Employer
incorporation or organization)						Identification No.)

1345 Avenue of the Americas, New York, New York                     10105

(Address of principal executive offices) (Zip Code)

(212) 554-1234

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of Exchange on which registered

Common Stock

EQH

New York Stock Exchange

Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A

EQH PR A

New York Stock Exchange

Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

EQH PR C

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01    Entry into a Material Definitive Agreement.

On August 25, 2025, Equitable Holdings, Inc. (the "Company") entered into amendments (the "Amendments") to the Reimbursement Agreements with Commerzbank AG, New York Branch, and MUFG Bank, Ltd., each as an issuer of letters of credit thereunder, to effect changes in terms similar to the provisions of the Revolving Credit Agreement, dated as of July 29, 2025, among the Company, the Subsidiary Account Parties party thereto, the banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, including amendments to financial covenants and related defined terms, among other changes. The Amendment with Commerzbank AG, New York Branch, also included addition of two years of extension options for Commitment Termination Date thereunder. The foregoing description of the Amendments does not purport to be complete and is subject to, and is qualified in its entirety by, reference to the full text of each Amendment, which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending September 30, 2025.

Item 1.02    Termination of a Material Definitive Agreement.

On August 21, 2025, the Company terminated the bilateral letter of credit facilities under the Reimbursement Agreements, each dated as of February 16, 2018 (as amended, supplemented or otherwise modified from time to time), with each of the following issuers of letters of credit: Barclays Bank PLC, Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A., Landesbank Hessen-Thüringen Girozentrale, acting through its New York Branch, and Natixis, New York Branch.

On August 26, 2025, the Company also terminated the bilateral letter of credit facility under the Reimbursement Agreement, dated as of February 16, 2018 (as amended, supplemented or otherwise modified from time to time), with Citibank Europe PLC.

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.			Description of Exhibit
104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			EQUITABLE HOLDINGS, INC.
Date: August 27, 2025			By:			/s/ Ralph Petruzzo
			Name:			Ralph Petruzzo
			Title:			Deputy General Counsel

FAQ

What did Equitable Holdings (EQH) report on the 8-K about letters of credit?

The company reported termination of bilateral letter of credit facilities under its reimbursement agreements with six banks, effective on Aug 21, 2025 and Aug 26, 2025.

Which counterparties were affected by EQH's termination of reimbursement agreements?

The affected counterparties are Barclays Bank PLC, Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A., Landesbank Hessen-Thüringen Girozentrale (New York Branch), Natixis, New York Branch, and Citibank Europe PLC.

When were the terminated reimbursement agreements originally dated?

The reimbursement agreements referenced were originally dated Feb 16, 2018 (as amended or modified).

Does the filing state whether replacement credit facilities were put in place?

No. The filing does not disclose any replacement facilities or changes to contingent funding arrangements.

Is the termination described as material in the 8-K?

Yes. The 8-K lists the termination of these bilateral letter of credit facilities under the reimbursement agreements as a material definitive agreement event.